Yahoo
NasdaqCM - Delayed Quote USD

Genenta Science S.p.A. (GNTA)

0.9601 +0.0096 (+1.01%)
At close: September 4 at 4:00:01 PM EDT
0.9601 -0.0039 (-0.40%)
After hours: September 4 at 4:04:02 PM EDT
Chart Range Bar
Loading chart for GNTA
  • Previous Close 0.9505
  • Open 0.9373
  • Bid 1.5300 x 500
  • Ask 1.3300 x 100
  • Day's Range 0.9373 - 0.9900
  • 52 Week Range 0.5500 - 10.0000
  • Volume 31,642
  • Avg. Volume 139,361
  • Market Cap (intraday) 46.293M
  • Beta (5Y Monthly) 0.72
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3800
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring majority or full ownership of privately held, established companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy span aerospace, defense, national security (including cybersecurity), and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

www.genenta.com

9

Full Time Employees

December 31

Fiscal Year Ends

Industrials

Sector

Conglomerates

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 9/6/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

GNTA
32.39%
MSCI WORLD (^990100-USD-STRD)
12.56%

1-Year Return

GNTA
72.57%
MSCI WORLD (^990100-USD-STRD)
18.99%

3-Year Return

GNTA
83.42%
MSCI WORLD (^990100-USD-STRD)
68.72%

5-Year Return

GNTA
90.45%
MSCI WORLD (^990100-USD-STRD)
0.00%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -17.67%

  • Return on Equity (ttm)

    -38.03%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -6.53M

  • Diluted EPS (ttm)

    -0.3800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    28.15M

  • Total Debt/Equity (mrq)

    34.81%

  • Levered Free Cash Flow (ttm)

    -3.1M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: